Clinical trial
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
NCT00460590 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00460590 |
|---|---|
| Title | Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town |
| Official title | A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine MVA85A, in Healthy Volunteers With no Evidence of Infection With Mycobacterium Tuberculosis, in Cape Town |
| Lead sponsor | University of Oxford, Other |
| Collaborators | University of Cape Town |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Biological |
| Interventions | MVA 85A |
| Enrollment | 36 |
| Start date | Oct 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Apr 16, 2007 |
| Last update posted | Aug 7, 2008 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: